Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MIMDaroo Pharmaceutical is an Iranian biotechnology company focused on the research, development, and commercialization of novel therapeutic agents derived from natural and synthetic sources. The company gained international recognition for developing Angipars, a herbal-based treatment for diabetic foot ulcers, and IMOD, an immunomodulator used in the management of HIV/AIDS. MIMDaroo operates with a focus on addressing unmet medical needs in chronic wound care and infectious diseases through innovative pharmacological approaches. Their business model integrates advanced research with large-scale manufacturing to serve both domestic and regional healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MIMDaroo.